SLI STANDARD LITHIUM LTD. IFRS
Chemicals & Allied Products · NYSE · SEC CIK 1537137 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 · USD | FY2024*2024-12-31 · USD | FY2024*2024-06-30 · USD | FY2023*2023-06-30 · CAD | FY2022*2022-06-30 · CAD |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| Operating income | -$27.39M | — | -$33.52M | -45.29M | -38.42M |
| Interest expense | $33,000 | — | $62,000 | 46,000 | 19,000 |
| Pretax income | -$51.49M | — | $131.67M | -41.99M | — |
| Income tax | -$3.09M | — | $25.87M | — | — |
| Net income | -$48.40M | -$1.29M | $105.80M | -41.99M | -38.10M |
| EPS (basic) | -0.23 | — | 0.60 | -0.25 | -0.25 |
| EPS (diluted) | -0.23 | — | 0.59 | -0.25 | -0.25 |
| Weighted avg. shares (diluted) | 206.37M | — | 179.42M | 168.58M | 155.45M |
| Banking | |||||
| Net interest income | $1.86M | — | $922,000 | 3.35M | 336,000 |
| Balance sheet | |||||
| Cash & equivalents | $152.31M | $31.18M | $38.67M | 59.61M | 129.06M |
| Receivables | — | — | $303,000 | 468,000 | 1.14M |
| Current assets | $157.69M | $33.30M | $41.52M | 62.05M | 131.80M |
| PP&E, netmay include right-of-use assets (IFRS) | $1.04M | $1.63M | $1.51M | 2.77M | 985,000 |
| Intangibles | $967,000 | $943,000 | $985,000 | 1.43M | 1.50M |
| Total assets | $386.52M | $259.50M | $287.29M | 173.50M | 183.65M |
| Current liabilities | $10.09M | $5.77M | $12.60M | 13.25M | 6.78M |
| Short-term debt | $0 | $0 | — | — | — |
| Total liabilities | $32.56M | $31.44M | $38.91M | 14.12M | 7.12M |
| Shareholders' equity | $353.96M | $228.06M | $248.38M | 159.38M | 176.53M |
| Cash flow statement | |||||
| Operating cash flow | — | — | — | — | — |
| Capital expenditure | — | — | $803,000 | 199,000 | — |
| Investing cash flow | -$29.76M | — | -$2.75M | -53.27M | -9.37M |
| Financing cash flow | $163.58M | — | $14.70M | 5.02M | 131.93M |
| Stock-based compensation | $6.59M | — | $7.94M | 16.98M | 4.28M |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.